CBD is a hot topic of discussion around the country. The promise of benefits from a cannabinoid without the side effects of THC has legislators, patients and medical professionals looking for more answers. This panel will explore the various claims of CBD and clarify appropriate policies moving forward.
Dr. Jahan Marcu, Ph.D.
Suzanne Sisley, M.D.
Martin A. Lee is the director of Project CBD (projectcbd.org), an information service focusing on cannabis science and therapeutics. He is the author of four books, including most recently Smoke Signals: A Social History of Marijuana – Medical, Recreational and Scientific (Scribner). The American Botanical Council gave Smoke Signals its James A. Duke Excellence in Botanical Literature Award.
Jahan Marcu, Ph. D., is currently the Senior Scientist and Chief Auditor for Americans for Safe Access and the Patient Focused Certification (PFC) Program. His is also on the Board of Directors of the International Association for Cannabinoids as Medicine (IACM). Dr. Marcu is the Director of Research and Development at Green Standard Diagnostics Inc. He received his Ph.D. for significant contributions to the study of the structure and function of the CB1 receptor, and the role of the endocannabinoid system in bone. Before earning his Ph.D., Dr. Marcu worked at the California Pacific Medical Center Research Institute studying the anti-cancer properties of compounds from the cannabis plant (Published in the Journal of Molecular Cancer Therapeutics) and on analytical Cannabis research projects in Holland. He is also an author of the American Herbal Pharmacopeia's Cannabis Monograph and one of the auditors for the Patient Focused Certification (PFC) program; an enforcement and oversight program that ensures that basic product safety protocols are followed at Cannabis operations. Dr. Marcu is a recipient of the Billy Martin research award from the International Cannabinoid Research Society.
Dean Petkanas is Chairman & Chief Executive Officer for KannaLife Sciences Inc. KannaLife is a bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants.
Dr. Suzanne A. Sisley practices medicine in Scottsdale, AZ and specializes in Internal Medicine and Psychiatry. She is widely known for her research into potential medical uses of marijuana to treat veterans diagnosed with PTSD. Dr. Sisley's research is supported by the Multidisciplinary Association for Psychedelic Studies (MAPS), a California-based nonprofit organization.
Eric Steenstra is a founder and the President of Vote Hemp, a national single-issue grassroots non-profit group based in Washington, DC. Vote Hemp’s mission is to change state and federal laws to allow American farmers to grow hemp commercially and the organization has been instrumental in getting pro-hemp legislation passed in more than 30 states as well as at the federal level.